Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: Consequences for pravastatin pharmacokinetics

Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics

1999 • 2,458 citations

Molecular Identification and Characterization of Novel Members of the Human Organic Anion Transporter (OATP) Family

2000 • 636 citations

A Novel Human Hepatic Organic Anion Transporting Polypeptide (OATP2)

1999 • 630 citations

A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane

2000 • 611 citations

Polymorphisms in OATP-C

2001 • 605 citations

Molecular Basis of Ethnic Differences in Drug Disposition and Response

2001 • 595 citations

Identification of a Novel Gene Family Encoding Human Liver-specific Organic Anion Transporter LST-1

1999 • 546 citations

MOLECULAR MECHANISMS OF GENETIC POLYMORPHISMS OF DRUG METABOLISM

1997 • 540 citations

Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene.

2001 • 538 citations

Hepatic Uptake of Bilirubin and Its Conjugates by the Human Organic Anion Transporter SLC21A6

2001 • 507 citations

Identification and Characterization of Human Organic Anion Transporter 3 Expressing Predominantly in the Kidney

2001 • 501 citations

Molecular Cloning and Characterization of a New Multispecific Organic Anion Transporter from Rat Brain

1999 • 486 citations

Genetic Polymorphisms of Human Organic Anion Transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): Allele Frequencies in the Japanese Population and Functional Analysis

2002 • 316 citations

Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects

2001 • 235 citations

Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics.

1996 • 218 citations

Functional characterization of human organic anion transporting polypeptide B (OATP-B) in comparison with liver-specific OATP-C.

2001 • 212 citations

Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function

2002 • 188 citations

Disposition of pravastatin sodium, a tissue‐selective HMG‐CoA reductase inhibitor, in healthy subjects.

1990 • 174 citations

Na(+)-independent multispecific anion transporter mediates active transport of pravastatin into rat liver

1993 • 154 citations

Functional Involvement of Rat Organic Anion Transporter 3 (rOat3;Slc22a8) in the Renal Uptake of Organic Anions

2002 • 141 citations

A Naturally Occurring Mutation in the SLC21A6Gene Causing Impaired Membrane Localization of the Hepatocyte Uptake Transporter

2002 • 140 citations

Biotransformation of pravastatin sodium in humans.

1991 • 108 citations

Cytochrome P450 Pharmacogenetics in Drug Development: In Vitro Studies and Clinical Consequences

2002 • 94 citations

Suggestions for the nomenclature of human alleles: relevance to ecogenetics, pharmacogenetics and molecular epidemiology

2000 • 93 citations

Ethnicity influences morphine pharmacokinetics and pharmacodynamics

2001 • 90 citations

Proton-cotransport of pravastatin across intestinal brush-border membrane.

1995 • 84 citations

Pravastatin, an HMG-CoA reductase inhibitor, is transported by rat organic anion transporting polypeptide, oatp2.

1999 • 78 citations

Uptake is the rate-limiting step in the overall hepatic elimination of pravastatin at steady-state in rats.

1996 • 62 citations

TISSUE-SELECTIVE UPTAKE OF PRAVASTATIN IN RATS: CONTRIBUTION OF A SPECIFIC CARRIER-MEDIATED UPTAKE SYSTEM

1996 • 45 citations

Gastrointestinal Absorption of Pravastatin in Healthy Subjects

1995 • 38 citations

Tissue selective drug delivery utilizing carrier-mediated transport systems

1999 • 35 citations

Hepatoselective carrier-mediated sodium-independent uptake of pravastatin and pravastatin-lactone

1993 • 24 citations

Pharmacokinetic and pharmacodynamic evaluation for tissue-selective inhibition of cholesterol synthesis by pravastatin.

1998 • 18 citations